D.G. v. Secretary of Heath and Human Services

CourtUnited States Court of Federal Claims
DecidedJune 17, 2020
Docket11-577
StatusUnpublished

This text of D.G. v. Secretary of Heath and Human Services (D.G. v. Secretary of Heath and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
D.G. v. Secretary of Heath and Human Services, (uscfc 2020).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: May 22, 2020 No. 11-577V UNPUBLISHED

D.G., Special Master Horner Petitioner, v. Attorneys’ Fees and Costs; SECRETARY OF HEALTH AND Protracted Case HUMAN SERVICES,

Respondent.

Lisa A. Roquemore, Law Office of Lisa A. Roquemore, Rancho Santa Margarita, C.A., for Petitioner. Debra A. Filteau Begley, United States Department of Justice, Washington, D.C., for Respondent.

DECISION ON ATTORNEYS’ FEES AND COSTS1

On September 9, 2011, D.G. (“petitioner”) filed a petition for compensation pursuant to the National Vaccine Injury Compensation Program.2 42 U.S.C. §§ 300aa- 10 to 34 (2012). Initially, the petition alleged that an influenza vaccine administered on August 23, 2009, caused D.G. to suffer muscle weakness, fatigue, dizziness, excessive sweating, seizures, fainting, vasovagal syncope, benign systolic murmur, positive ANA, multiple somatic complaints, anxiety, dystonia, neurocardiogenic syncope, and postural orthostatic tachycardia syndrome. (ECF No. 1.) However, shortly before the conclusion of the case, petitioner filed an amended petition narrowing her allegations to injuries of autoimmune autonomic neuropathy/dysautonomia, myasthenia gravis, and

1I intend to post this Ruling on the United States Court of Federal Claims’ website. This means the Ruling will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims’ website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services).

2 National Childhood Vaccine Injury Act of 1986, Pub L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). autoimmunity to glutamate acid decarboxylase (“GAD”). (ECF No. 188.) On May 24, 2019, the previously assigned special master issued her entitlement decision dismissing the petition – that decision also contains a description of the extensive procedural history of this matter. D.G. v. Sec’y of Health & Human Servs., No. 11-577V, 2019 WL 2511769 (Fed. Cl. Spec. Mstr. May 24, 2019) (ECF No. 196). On June 7, 2019, this case was reassigned to me. (ECF No. 198.)

On November 6, 2019, petitioner filed an application for attorneys’ fees and costs. (ECF No. 203 (“Fees App.”).) Petitioner requests total attorneys’ fees and costs in the amount of $634,742.89, which includes:

• $466,720.20 in attorneys’ fees generated by her current counsel of record, Ms. Roquemore; and • $99,667.43 in costs incurred by Ms. Roquemore (including $94,399.54 in expert costs from Dr. Steinman and $5,267.89 in additional litigation expenses); and • $61,102.95 in attorneys’ fees billed by her former counsel of record, Mr. Krakow; and • $3,649.91 in costs incurred by Mr. Krakow; and • $3,602.40 in litigation costs incurred by petitioner herself.

(Fees App. at 2.) 3 Respondent responded to the motion on November 20, 2019, indicating that he “defers to the Court regarding whether the statutory requirements for an award of attorneys’ fees and costs are met in this case” and, if so, requesting that I exercise my discretion to determine a reasonable award for attorneys’ fees and costs. (Resp. at 2–3; ECF No. 205.) Petitioner filed a reply on November 21, 2019, reiterating her belief that her request is reasonable. (ECF No. 206.)

This matter is now ripe for consideration. Petitioner previously received an award of interim attorneys’ fees and costs in the amount of $44,961.65 on August 2, 2013, as well as an award of personal litigation expenses in the amount of $2,950.29 on July 1, 2014. Accordingly, the entirety of the attorneys’ fees and litigation costs ultimately sought in this case is $682,654.83. For the reasons described below, however, I now award final attorneys’ fees and costs in the reduced amount of $489,494.01.

I. Reasonable Attorneys’ Fees and Costs

In unsuccessful cases such as this, the Vaccine Act permits an award of reasonable attorneys’ fees and costs so long as the petition was brought in good faith

3 In fact, in her motion, petitioner indicates her request is for $638,373.96, which includes $66,384.83 in fees and costs for petitioner’s former counsel, Mr. Robert Krakow, and $96,399.54 in costs relating to Dr. Steinman’s work. However, the amounts cited in the motion for Mr. Krakow’s fees and costs do not match the amounts listed on his invoices. (Compare ECF No. 203, p. 2, and ECF No. 204-6, p. 15.) Additionally, in her reply, petitioner acknowledged that a $2,000.00 retainer for Dr. Steinman had already been reimbursed, reducing the total of Ms. Roquemore’s requested costs as well.

2 and with a reasonable basis. § 15(e). Here, respondent has raised no argument that this case lacked either good faith or a reasonable basis. Moreover, upon my review, I conclude that these requirements are met. Accordingly, the primary question presented relates to the reasonableness of the amount sought for attorneys’ fees and costs.

The Federal Circuit has approved the lodestar approach to determine reasonable attorneys’ fees and costs under the Vaccine Act. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1347 (Fed. Cir. 2008). This is a two-step process. Id. at 1347- 48. First, a court determines an “initial estimate . . . by ‘multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.’” Id. (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). Second, the court may make an upward or downward departure from the initial calculation of the fee award based on specific findings. Id. at 1348.

It is “well within the special master’s discretion” to determine the reasonableness of fees. Saxton v. Sec’y of Health & Human Servs., 3 F.3d 1517, 1521–22 (Fed. Cir. 1993); see also Hines v. Sec’y of Health & Human Servs., 22 Cl. Ct. 750, 753 (1991). (“[T]he reviewing court must grant the special master wide latitude in determining the reasonableness of both attorneys’ fees and costs.”). Applications for attorneys’ fees must include contemporaneous and specific billing records that indicate the work performed and the number of hours spent on said work. See Savin v. Sec’y of Health & Human Servs., 85 Fed. Cl. 313, 316–18 (2008).

Special masters can reduce a fee request sua sponte, without providing petitioners notice and opportunity to respond. See Sabella v. Sec’y of Health & Human Servs., 86 Fed. Cl. 201, 209 (2009). When determining the relevant fee reduction, special masters need not engage in a line-by-line analysis of petitioners’ fee application. Broekelschen v. Sec’y of Health & Human Servs., 102 Fed. Cl. 719, 729 (2011).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
D.G. v. Secretary of Heath and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dg-v-secretary-of-heath-and-human-services-uscfc-2020.